Ridge Augmentation Using a Self-Retaining Block Bone Material in Damaged Extraction Sockets: A Multi-Centre Randomized Controlled Clinical Trial

4 48

Cited 0 times in

Authors: Shinyoung Park ; Joo-Yeon Lee ; Jin-Young Park ; Young Woo Song ; Jae-Kook Cha ; Franz J Strauss ; Seung-Yun Shin ; Hyun-Chang Lim ; Ronald E Jung ; Ui-Won Jung ; Daniel S Thoma

MeSH: Adult ; Aged ; Alveolar Ridge Augmentation* / methods ; Bone Substitutes* / therapeutic use ; Collagen / therapeutic use ; Cone-Beam Computed Tomography ; Female ; Humans ; Male ; Middle Aged ; Tooth Extraction ; Tooth Socket* / diagnostic imaging ; Tooth Socket* / surgery ; Treatment Outcome

Keywords: alveolar bone grafting ; alveolar ridge augmentation ; dental implantation ; tooth extraction

Abstract: Aim: To compare the dimensional stability of a self-retaining synthetic block bone (srBB) and synthetic bone particles (SBP) for alveolar ridge augmentation (ARA) in damaged extraction sockets.

Materials and methods: ARA was randomly performed in two centres on 57 participants presenting damaged extraction socket in a non-molar tooth: (i) srBB and collagen membrane (srBB group, n = 29) or (ii) SBP and collagen membrane (SBP group, n = 28). Cone beam computed tomography (CBCT) was performed immediately after ARP (baseline, T0) and at 6 months (T1). T0 and T1 CBCTs were superimposed, and horizontal widths (H0-H5), vertical heights and volume changes were assessed using t-test.

Results: Due to wound dehiscence, srBB was removed in 10 patients. The change in horizontal width at the most coronal level (H0) was significantly lower for srBB compared to SBP (srBB: 0.8 ± 1.0 mm; SBP: 1.9 ± 2.2 mm, p < 0.05). Significantly less volume decrease was seen at the bucco-coronal level for srBB (srBB: 3.2 ± 0.6 mm3; SBP: 10.4 ± 2.3 mm3, p < 0.05).

Conclusion: Compared to synthetic bone particles, synthetic bone blocks have the potential to more effectively augment and maintain the coronal horizontal dimension and width of damaged extraction sockets for up to 6 months. However, this advantage is offset by their relatively high rates of early wound dehiscence.

Trial registration: Korean Clinical Research information service (CRIS) (KCT0005462).